Piramal Pharma Limited Announces Results for Q3 and 9M FY26
PR Newswire —
MUMBAI, India, Jan. 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Third Quarter (Q3) and Nine Month (9M) ended 31st December 2025....